CO24 Daratumumab in Combination with Lenalidomide and Dexamethasone Improves Survival in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: A Parametric Network Meta-Analysis in a United Kingdom Setting

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.097
https://www.valueinhealthjournal.com/article/S1098-3015(23)03227-8/fulltext
Title : CO24 Daratumumab in Combination with Lenalidomide and Dexamethasone Improves Survival in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: A Parametric Network Meta-Analysis in a United Kingdom Setting
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03227-8&doi=10.1016/j.jval.2023.09.097
First page :
Section Title :
Open access? : No
Section Order : 10413
Categories :
Tags :
Regions :
ViH Article Tags :